Acasti Pharma reported $1000 in Ordinary Share Capital for its fiscal quarter ending in December of 2024.





Ordinary Share Capital Change Date
Acasti Pharma USD 1000 261.04M Dec/2024
Addus HomeCare USD 18.48M 76K Dec/2025
Amarin USD 20.81M 13K Dec/2025
Cassava Sciences USD 48.31M 0 Dec/2025
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Option Care Health USD 156.86M 6.89M Dec/2025
Organigram Holdings CAD 135.13M 671.75K Dec/2025
Tilray USD 116.52M 5.01M Sep/2025